TRML - Tourmaline Bio, Inc.

QQQ $ 476.00 $ 5.61 (1.19 %)

DIA $ 416.44 $ 2.30 (0.56 %)

SPY $ 563.62 $ 5.33 (0.95 %)

TLT $ 96.60 $ -1.04 (-1.07 %)

GLD $ 231.30 $ -1.66 (-0.71 %)

Previous Close

$ 16.85

Open

$ 17.31

Bid

$ 16.89 x 200

Ask

-- x --

Day's Range

$ 16.23 - $ 17.31

52 Week Range

$ 9.18 - $ 48.31

Volume

357,499

Average Volume

Market Cap

432.06M

Beta (5Y Monthly)

$ 1.68

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-13-2024	03-31-2024	10-Q
3	03-19-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-14-2023	06-30-2023	10-Q
6	05-15-2023	03-31-2023	10-Q
7	03-31-2023	12-31-2022	10-K
8	11-10-2022	09-30-2022	10-Q
9	08-15-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-17-2022	12-31-2021	10-K
12	11-12-2021	09-30-2021	10-Q
13	08-12-2021	06-30-2021	10-Q
14	06-14-2021	03-31-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Tour...
08/12/2024 11:31:00

HC Wainwright & Co. analyst Yi Chen reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $48 price target.

Tourmaline Bio Q2 2024 Adj EPS $(0.68) Bea...
08/08/2024 12:51:11

Tourmaline Bio (NASDAQ:TRML) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.71...

Tourmaline Bio Presents Phase 2 TRANQUILIT...
08/02/2024 20:31:17

Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability,...

Tourmaline Bio Names Ryan Robinson As CFO,...
06/27/2024 12:06:10

HC Wainwright & Co. Reiterates Buy on Tour...
05/14/2024 13:57:43

HC Wainwright & Co. analyst Yi Chen reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $48 price target.

Tourmaline Bio Ended The First Quarter Wit...
05/13/2024 11:19:20

Tourmaline Bio Q1 2024 GAAP EPS $(0.55) Be...
05/13/2024 11:18:29

Truist Securities Reiterates Buy on Tourma...
03/25/2024 16:27:18

Truist Securities analyst Robyn Karnauskas reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $74 price target.

Why FactSet Research Shares Are Trading Lo...
03/21/2024 18:39:11

Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-th...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
03/21/2024 17:31:11

dow-jumps-200-points-us-weekly-jobless-claims-fall

Dow Jumps 200 Points; US Weekly Jobless Cl...
03/21/2024 13:47:49

U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Thursday. Following the market o...

12-health-care-stocks-moving-in-thursdays-pre-market-session

12 Health Care Stocks Moving In Thursday's...
03/21/2024 13:05:49

Five Below Posts Q4 Results, Joins LexinFi...
03/21/2024 10:15:31

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Thursday.

HC Wainwright & Co. Reiterates Buy on Tour...
03/20/2024 10:46:31

HC Wainwright & Co. analyst Yi Chen reiterates Tourmaline Bio (NASDAQ:TRML) with a Buy and maintains $48 price target.

Tourmaline Bio Q4 EPS $(0.81) Up From $(5....
03/19/2024 11:07:57

Tourmaline Bio (NASDAQ:TRML) reported quarterly losses of $(0.81) per share. This is a 85.3 percent increase over losses of $(5...

Tourmaline Bio Reports Pricing Of Public O...
01/25/2024 12:11:53

The gross proceeds to Tourmaline from the offering, before deducting underwriting discounts and commissions and offering expens...

Tourmaline Bio Announces Proposed Public O...
01/24/2024 21:34:23

Tourmaline Bio, Inc. ("Tourmaline") (NASDAQ:TRML), a late-stage clinical biotechnology company developing transformativ...

12-health-care-stocks-moving-in-wednesdays-after-market-session

12 Health Care Stocks Moving In Wednesday'...
01/24/2024 21:31:07

Tourmaline Bio Announces Expected Upcoming...
01/08/2024 12:20:22

Tourmaline plans to accelerate the initiation of a pivotal Phase 3 trial in 2024 evaluating subcutaneous TOUR006 every 8 week...

tdcx-receives-preliminary-non-binding-proposal-letter-joins-pure-storage-dyne-therapeutics-and-other-big-stocks-moving-higher-on-wednesday

TDCX Receives Preliminary Non-binding Prop...
01/03/2024 15:24:25

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) r...